CPT® Code 87300

1. Indications

The procedure associated with CPT® Code 87300 is indicated for the detection of infectious agents in various clinical scenarios. The following conditions may warrant the use of this immunofluorescent technique:

• Infectious Disease Diagnosis The procedure is performed to identify the presence of multiple pathogenic organisms in a tissue sample, aiding in the diagnosis of infectious diseases.
• Unexplained Symptoms It may be indicated in patients presenting with unexplained symptoms that suggest an underlying infectious process, where traditional diagnostic methods may not provide conclusive results.
• Monitoring Treatment Efficacy This technique can also be utilized to monitor the effectiveness of ongoing treatment for infections, allowing for adjustments in therapeutic strategies based on the detection of specific pathogens.

2. Procedure

The procedure for CPT® Code 87300 involves several key steps to ensure accurate detection of infectious agents. Each step is critical to the overall effectiveness of the diagnostic process.

• Step 1: Sample Collection A tissue sample is collected from the patient, which may involve a biopsy or aspiration, depending on the clinical context. The sample must be handled carefully to preserve its integrity for subsequent analysis.
• Step 2: Application of Fluoroscopic Dye Once the tissue sample is obtained, a fluoroscopic dye is applied. This dye is essential for enhancing the visibility of the sample under a fluorescent microscope, as it binds to the antigens present in the infectious agents.
• Step 3: Microscopic Examination The treated sample is then examined under a fluorescent microscope. The healthcare professional looks for specific fluorescence patterns that indicate the presence of multiple pathogenic organisms, as the dye will emit light when bound to the antigens of these organisms.

3. Post-Procedure

After the procedure associated with CPT® Code 87300, the patient may require monitoring for any immediate reactions to the tissue collection. The results of the immunofluorescent examination will typically be available within a specified timeframe, allowing for timely diagnosis and treatment decisions. It is important for healthcare providers to communicate the findings to the patient and discuss any necessary follow-up actions or additional testing that may be required based on the results. Additionally, proper documentation of the procedure and findings is essential for compliance and billing purposes.